Findings published in NEJM show that microarray finds significantly more clinically relevant information than current method Second study in NEJM shows significant advantages of microarray for ...
A qualitative study conducted in Ireland indicates that patients and healthcare professionals view microarray patches as a ...
In an outbreak of Legionnaires' disease, finding the exact source as quickly as possible is essential to preventing further infections. To date, a standard analysis takes days. Researchers at the ...
A large study from Children's Hospital Boston and the Boston-based Autism Consortium finds that a genetic test that samples the entire genome, known as chromosomal microarray analysis, has about three ...
A single genetic test could potentially replace the current two-step approach to diagnosing rare developmental disorders in children. This shift could enable earlier diagnoses for families and save ...
The Netherlands Cancer Institute in Amsterdam is to become the first institution in the world to use microarray techniques for the routine prognostic screening of cancer patients. Aiming for a June ...
This initiative supports Astra Biotech’s aim of facilitating early diagnosis of individuals’ risk factors through innovative assays. In this way long-term effects of a disease can be minimised and ...
Due to its higher resolution, oligo array CGH has recently made strong inroads in the cytogenetic lab. It’s not surprising. With an increased sensitivity of more than 1,000-fold, microarrays can ...
A large, multi-center clinical trial led by researchers from Columbia University Medical Center (CUMC) shows that a new genetic test resulted in significantly more clinically relevant information than ...
New York, NY—A large, multi-center clinical trial led by researchers from Columbia University Medical Center (CUMC) shows that a new genetic test resulted in significantly more clinically relevant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results